Inhaling graphene is safe, according to human trial

Inhaling an ultra-pure form of the ‘wonder material’ graphene did not produce any short-term adverse effects on lung and cardiovascular function in a small group of healthy volunteers. The first-in-human study opens the door to developing a novel targeted drug delivery method to treat diseases such as cancer.